Zepbound, Eli Lilly’s weight loss drug, can now be used to treat obstructive sleep apnea in adults with obesity, the FDA said.

The new class of weight-loss drugs isn't just for diabetes and weight loss. Eli Lilly results from a large-scale trial show they can treat sleep apnea.

That opens the door for broader access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss. Demand for the injection has soared over the last year ...

The weekly injection is now the first drug treatment option cleared for patients with obesity and moderate-to-severe obstructive sleep apnea, or OSA, which refers to breathing interrupted during sleep ...

A series of class actions over the exclusion of coverage for GLP-1 weight loss drugs is testing several legal strategies ...

Fact checked by Nick Blackmer Zepbound may lead to more weight loss than Wegovy, with participants losing 20.2% of their body weight in a clinical trial.Participants on Zepbound had a greater decrease ...

Millions of Americans have tried GLP-1 medications. We're covering the many changes the drugs have brought to users' lives in our On My Weigh series. (Photo illustration: Yahoo News; photos: Getty ...

When Zepbound, Eli Lilly's highly anticipated weight loss drug, hit the market a year and a half ago, it marked a turning point for the accessibility of weight loss drugs. Since then, Zepbound, the ...

LillyDirect is a legitimate, direct-to-consumer platform that offers authentic Eli Lilly medication. This platform accepts insurance and offers self-pay options. LillyDirect is partnered with licensed ...